Continuum Advisory’s Bio-Techne TECH Stock Holding History

Continuum Advisory’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4	Closed	-$235	–	1444
2025 Q1	$235	Hold	4	–	–	﹤0.01%	1620
2024 Q4	$288	Hold	4	–	–	﹤0.01%	1800
2024 Q3	$290	Buy	+4	New	+$301	﹤0.01%	1862

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Continuum Advisory's TECH Position: Q2 2025 in Review

Continuum Advisory sold out of Bio-Techne (TECH) in Q2 2025, closing a stake of 4 shares — an estimated $235 sold.

Continuum Advisory first reported a position in TECH in Q3 2024 and held it in 3 quarters. The position peaked at $290 in Q3 2024. 554 funds tracked by Wall St. Rank hold TECH as of Q2 2025.

Continuum Advisory reported no remaining Bio-Techne position as of Q2 2025 after selling out during the quarter.
Continuum Advisory sold 4 Bio-Techne shares in Q2 2025, an estimated $235.
Continuum Advisory first reported a position in Bio-Techne in Q3 2024 and held it in 3 quarters.
Continuum Advisory's Bio-Techne position peaked at $290 in Q3 2024.
554 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2025.

Based on Continuum Advisory's 13F filing for Q2 2025, filed 13 Aug 2025.